CA2322052C - Calcium salts of lipopeptide antibiotics, method for producing same and their use - Google Patents

Calcium salts of lipopeptide antibiotics, method for producing same and their use Download PDF

Info

Publication number
CA2322052C
CA2322052C CA002322052A CA2322052A CA2322052C CA 2322052 C CA2322052 C CA 2322052C CA 002322052 A CA002322052 A CA 002322052A CA 2322052 A CA2322052 A CA 2322052A CA 2322052 C CA2322052 C CA 2322052C
Authority
CA
Canada
Prior art keywords
calcium salt
formula
salt
calcium
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002322052A
Other languages
English (en)
French (fr)
Other versions
CA2322052A1 (en
Inventor
Laszlo Vertesy
Werner Aretz
Heinrich Decker
Eberhard Ehlers
Michael Kurz
Frank Rainer Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Publication of CA2322052A1 publication Critical patent/CA2322052A1/en
Application granted granted Critical
Publication of CA2322052C publication Critical patent/CA2322052C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002322052A 1998-02-25 1999-02-12 Calcium salts of lipopeptide antibiotics, method for producing same and their use Expired - Fee Related CA2322052C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19807972.9 1998-02-25
DE19807972A DE19807972A1 (de) 1998-02-25 1998-02-25 Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
PCT/EP1999/000930 WO1999043700A1 (de) 1998-02-25 1999-02-12 Lipopeptidantibiotika-calciumsalze, verfahren zu ihrer herstellung und verwendung

Publications (2)

Publication Number Publication Date
CA2322052A1 CA2322052A1 (en) 1999-09-02
CA2322052C true CA2322052C (en) 2009-09-29

Family

ID=7858906

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002322052A Expired - Fee Related CA2322052C (en) 1998-02-25 1999-02-12 Calcium salts of lipopeptide antibiotics, method for producing same and their use

Country Status (15)

Country Link
US (1) US6624143B1 (cg-RX-API-DMAC7.html)
EP (1) EP1068223B1 (cg-RX-API-DMAC7.html)
JP (1) JP4402833B2 (cg-RX-API-DMAC7.html)
AR (1) AR016713A1 (cg-RX-API-DMAC7.html)
AT (1) ATE223433T1 (cg-RX-API-DMAC7.html)
AU (1) AU2725299A (cg-RX-API-DMAC7.html)
CA (1) CA2322052C (cg-RX-API-DMAC7.html)
CO (1) CO4790157A1 (cg-RX-API-DMAC7.html)
DE (2) DE19807972A1 (cg-RX-API-DMAC7.html)
DK (1) DK1068223T3 (cg-RX-API-DMAC7.html)
ES (1) ES2182489T3 (cg-RX-API-DMAC7.html)
PT (1) PT1068223E (cg-RX-API-DMAC7.html)
TW (1) TW559623B (cg-RX-API-DMAC7.html)
WO (1) WO1999043700A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA991482B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1423656A (zh) 1999-12-15 2003-06-11 卡比斯特制药公司 作为抗菌剂的脂肽
BR0017026A (pt) 1999-12-15 2003-01-07 Cubist Pharm Inc Lipeptìdeos como agentes antibacterianos
IL150224A0 (en) 1999-12-15 2002-12-01 Cubist Pharm Inc Lipopeptides and pharmaceutical compositions containing the same
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
JP2004525108A (ja) † 2000-12-18 2004-08-19 キュービスト ファーマスーティカルズ インコーポレイテッド 精製リポペプチドの調製方法
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
US7125844B2 (en) 2002-01-03 2006-10-24 Migenix Inc. Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same
JP2007536200A (ja) 2003-07-17 2007-12-13 ミジェニックス インコーポレイテッド リポペプチド抗生物質誘導体の組成物およびその使用方法
US7795207B2 (en) 2005-11-21 2010-09-14 Harald Labischinski Lipopeptide compositions
DE102005056194A1 (de) * 2005-11-21 2007-07-12 Combinature Biopharm Ag Neue Lipopeptid Zusammensetzungen
GB0821540D0 (en) * 2008-11-25 2008-12-31 Merlion Pharmaceuticals Pte Ltd Lipopeptide compounds and their use
NZ594019A (en) * 2008-12-22 2013-08-30 Cubist Pharm Inc Novel antibacterial agents for the treatment of gram positive infections
CA2781666C (en) 2009-11-23 2017-02-21 Cubist Pharmaceuticals, Inc. Lipopeptide compositions and related methods
WO2017173932A1 (en) * 2016-04-08 2017-10-12 Versitech Limited Antibacterial cyclic lipopeptides
US11667674B2 (en) 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800162A (en) * 1987-04-01 1989-01-24 Sepracor, Inc. Method for resolution of steroisomers in multiphase and extractive membrane reactors
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US5039789A (en) * 1988-04-11 1991-08-13 Eli Lilly And Company A54145 cyclic peptides
US6309440B1 (en) * 1998-08-25 2001-10-30 Thomas T. Yamashita Method and composition for promoting and controlling growth of plants
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
WO1998057923A1 (en) * 1997-06-18 1998-12-23 Fujisawa Pharmaceutical Co., Ltd. New production process

Also Published As

Publication number Publication date
TW559623B (en) 2003-11-01
ZA991482B (en) 1999-08-25
DE19807972A1 (de) 1999-08-26
DE59902568D1 (de) 2002-10-10
AU2725299A (en) 1999-09-15
JP4402833B2 (ja) 2010-01-20
WO1999043700A1 (de) 1999-09-02
JP2002528382A (ja) 2002-09-03
PT1068223E (pt) 2003-01-31
US6624143B1 (en) 2003-09-23
ATE223433T1 (de) 2002-09-15
EP1068223B1 (de) 2002-09-04
AR016713A1 (es) 2001-07-25
EP1068223A1 (de) 2001-01-17
DK1068223T3 (da) 2002-12-30
CA2322052A1 (en) 1999-09-02
ES2182489T3 (es) 2003-03-01
CO4790157A1 (es) 1999-05-31

Similar Documents

Publication Publication Date Title
US6624143B1 (en) Calcium salts of lipopeptide antibiotics, method for producing same and their use
EP1908770B1 (en) Methods for preparing purified lipopeptides
US8846610B2 (en) Methods for preparing purified lipopeptides
US5936062A (en) Process for preparing certain aza cyclohexapeptides
DE60131085T2 (de) Antimikrobielle sulfonamide-derivate von lipopeptidantibiotika
AU660682B2 (en) Novel glycopeptides, a process for their preparation and their use
CN108203723B (zh) 一种发酵生产高含量多黏菌素b1的方法
RU2110578C1 (ru) Штамм amycolatopsis orientalis subsp. eremomycini вкпм-s892 - продуцент антибиотика эремомицина и способ получения антибиотика эремомицина
EA016608B1 (ru) Антибиотик 107891, его фармацевтически приемлемые соли, фармацевтическая композиция и применение
CA2047997C (en) Antibiotic, balhimycin, a process for its production and its use as pharmaceutical
US5451570A (en) Antibiotic, balhimycin, a process for its production and its use as pharmaceutical
EP0535968B1 (en) Cyclohexapeptidyl hydroxypropionitrile compounds
US5721208A (en) Glycopeptides a process for their preparation and their use
JP2003113192A (ja) 抗生物質wap−2607b、その製造法及び抗菌剤
HK1108582B (zh) 制备纯化脂肽的方法

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160212